Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cedarburg Hauser Appoints CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Cedarburg Hauser Appoints CEO

Lynch to oversee all scientific operations

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

John K. Lynch, Ph.D. has been appointed chief scientific officer at Cedarburg Hauser Pharmaceuticals. In his new role, Dr. Lynch will oversee all scientific operations including the process development, R&D and analytical groups.
 
Dr. Lynch has served as director of R&D for the last three years, where he oversaw development projects and led the scientific team. Prior to joining the company, Dr. Lynch spent 15 years at Abbott Laboratories, working on a variety of process development and medicinal chemistry projects.
 
“Dr. Lynch’s promotion is well deserved,” said Cedarburg Hauser’s chief executive officer, Tony Laughrey. “In his time at Cedarburg Hauser, John has successfully led Cedarburg Hauser’s research and development efforts and is the ideal person to head-up the company’s scientific operations.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics